Holen Sie sich die Stockscreener-App
0.1902
20.48%
-0.049
Vorhandelsmarkt:
.20
0.0098
+5.15%
Schlusskurs vom Vortag:
$0.2392
Offen:
$0.2234
24-Stunden-Volumen:
7.81M
Relative Volume:
0.72
Marktkapitalisierung:
$6.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-35.76%
1M Leistung:
-42.57%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.1159
$0.23
1-Wochen-Bereich:
$0.1159
$0.40
52-Wochen-Spanne:
$0.1159
$2.22
Profusa Inc Stock (PFSA) Company Profile
Firmenname
Profusa Inc
Sektor
Branche
Telefon
212-494-9022
Adresse
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Vergleichen Sie PFSA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.1902 | 9.99M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Profusa Inc Aktie (PFSA) Neueste Nachrichten
Profusa Inc (PFSA) looking to reclaim success with recent performance - setenews.com
Profusa outlines revenue plan, targets EU commercial launch of Lumee in early Q2 2026 - MSN
Profusa outlines EU launch of tissue oxygen monitoring in 2026 By Investing.com - Investing.com South Africa
Profusa outlines EU launch of tissue oxygen monitoring in 2026 - Investing.com
Profusa Unveils Strategic Plan for Revenue Growth - TipRanks
Profusa, Inc. Outlines Path to $250 Million Revenue by 2030 - TradingView
Profusa (PFSA) furnishes press release and investor presentation | PFSA SEC FilingForm 8-K - Stock Titan
Profusa (NASDAQ: PFSA) plans EU Lumee launch, targets up to $250M in revenue by 2030 - Stock Titan
Profusa (PFSA) Stock Skyrockets 36% on Milestone News – Can This Biotech Sensor Play Rebound? - ts2.tech
Why Profusa (PFSA) Stock Soared 36% After Hours? - Benzinga
Profusa, Inc.Common Stock (Nasdaq:PFSA) Stock Quote | User | malvern-online.com - FinancialContent
Profusa completes manufacturing milestones ahead of 2026 product launch - Investing.com
Profusa completes manufacturing milestones ahead of 2026 product launch By Investing.com - Investing.com Nigeria
Profusa IncOn track to provide inventory in Q1 2026 - MarketScreener
Profusa (NASDAQ: PFSA) to supply distributors in early 2026 as capacity exceeds needs by 2x - Stock Titan
Profusa Invests $1 Million in Digital Treasury Assets - MSN
Profusa expands European footprint for Lumee Oxygen platform By Investing.com - Investing.com Australia
Profusa expands European footprint for Lumee Oxygen platform - Investing.com
Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe - The Manila Times
Profusa expands sales footprint with new distributor for Lumee Oxygen platform in Europe - MarketScreener
Profusa Unveils Strategic Focus in Investor Update - TipRanks
Profusa, Inc. Expands Distribution of Lumee Oxygen Platform Across Major European Markets - Quiver Quantitative
Profusa Expands Sales Footprint with New Distributor for Lumee?? Oxygen Platform in Europe - MarketScreener
~35% EU Population Covered — Profusa Partners with Angiopro to Commercialize Lumee in Europe - Stock Titan
Profusa files prospectus relates to resale of up to 42.6 mln shares - MarketScreener
Profusa injects additional USD 1M into digital treasury assets - Medical Buyer
Profusa makes second $1 million bitcoin investment to hedge risks By Investing.com - ng.investing.com
Profusa invests additional $1 million in digital treasury assets - MSN
Profusa, Inc. announced that it has received $1 million in funding - MarketScreener
Profusa invests additional $1 million in bitcoin treasury assets By Investing.com - Investing.com
Profusa, Inc. Announces $1 Million Investment in Digital Treasury Assets to Support Biochemical Monitoring Technology - Quiver Quantitative
Second $1M Investment: Profusa Expands Bitcoin Digital Treasury Strategy; Ascent Funds $2M Tranche - Stock Titan
French vascular surgeon adopts Profusa’s oxygen monitoring tech By Investing.com - Investing.com Nigeria
French vascular surgeon adopts Profusa’s oxygen monitoring tech - Investing.com India
Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base - The Manila Times
8% of French CLTI Cases: Profusa's Lumee Technology Gains Major Adoption from Leading Surgeon Network - Stock Titan
Profusa’s Risky Vision for High-Tech Medical Sensors - Finimize
Profusa Restructures Securities Agreement for Flexibility - MSN
Profusa Faces Nasdaq Listing Compliance Challenges - MSN
Profusa receives Nasdaq notices for minimum value and bid price compliance - Investing.com
Profusa Approves $100 Million Equity Line of Credit - MSN
Finanzdaten der Profusa Inc-Aktie (PFSA)
Es liegen keine Finanzdaten für Profusa Inc (PFSA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.84%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):